Johnson & Johnson

Recent news

• Rating change
  RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $290
  Market Newswire · 2026/10/6
• UBS Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $320
  Market Newswire · 2026/10/9
• Rating change
  DBS Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $270
  Market Newswire · 2026/9/12
• BofA Securities Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $282
  Market Newswire · 2026/10/9
• Rating change
  TD Cowen Initiates Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $300
  Market Newswire · 2026/9/15
• Rating change
  Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating
  Market Newswire · 2026/8/5
• Rating change
  Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $282
  Market Newswire · 2026/10/2
• Rating change
  Scotiabank Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $305
  Market Newswire · 2026/9/28
• Rating change
  Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $303
  Market Newswire · 2026/10/5
• Rating change
  UBS Initiates Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $320
  Market Newswire · 2026/9/2
• Morgan Stanley Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $294
  Market Newswire · 2026/10/7
• Leerink Partners Maintains Johnson & Johnson(JNJ.US) With Buy Rating
  Market Newswire · 2026/10/8
• Rating change
  Guggenheim Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $287
  Market Newswire · 2026/8/6
• Rating change
  Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $298
  Market Newswire · 2026/8/13
• Rating change
  BofA Securities Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $278
  Market Newswire · 2026/9/29
• Rating change
  Goldman Sachs Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $282
  Market Newswire · 2026/8/26
• Rating change
  RBC Capital Initiates Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $287
  Market Newswire · 2026/9/18
• Rating change
  RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $287
  Market Newswire · 2026/9/11
• Rating change
  J.P. Morgan Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $285
  Market Newswire · 2026/9/29
• Guggenheim Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $287
  Market Newswire · 2026/10/7
• Rating change
  Argus Research Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $300
  Market Newswire · 2026/7/29
• Rating change
  Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $298
  Market Newswire · 2026/7/23
• UBS Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $320
  Market Newswire · 2026/9/22
• Rating change
  Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $272
  Market Newswire · 2026/7/23
• Johnson & Johnson (JNJ.US) seeks priority review in China for talquetotab, a therapy aimed at inhibiting tumor formation and growth.
  Zhitong Finance · 2026/9/24

Headlines are aggregated automatically and are not independently verified or edited by our team.